Whether your focus is on distribution, communications, patient support, payer strategies, or comprehensive market access, we hope this curated list piques your interest. Enjoy!

Market Access News You Can Use to Kick-Start 2024

• Market Access: An overnight sensation, 20+ years in the making (Med Ad News), by Megan Hall, EVP, Executive Creative Director, Entrée Health
• Navigating the Future: Key Market Access Trends to Watch in ’24 (Pharmaceutical Executive), by Kevin Cast, Partner, Archbow Consulting
• Advice for Pharma in 2024: Buckle Up (Life Science Leader) and Politics and Prescription Drugs: What’s Ahead in 2024 (podcast), featuring Al Jackson, Consultant, Valuate Health Consultancy
• ‘Perfect Storm’ Shines a Spotlight on Market Access (PharmaLive), featuring a Q&A with Andrew Gottfried, CEO, Entrée Health
• Solving Pharma’s Pull-Through Problem and Pharma Has a Pull-Through Problem – The Answer is Data (PM360), featuring Access Next.
• Risk vs. Reward: A Must-Have Contracting Guide for Specialty Pharmacy Services (whitepaper), by Archbow Consulting
• Inflation Reduction Act: Looking Ahead to 2024 (POV), by Dina Steinfurth, Managing Director, Valuate Health Consultancy
• Trade & Channel Strategies 2023: IRA—All the Things Beyond Price Negotiations That Will Impact Your Business, by Douglas Bock, Partner, Archbow Consulting
• Trade & Channel Strategies 2023: An Interview with Douglas Bock of Archbow Consulting
• From Med Ad News’s Annual Agency Roundtable:
  • Looking ahead to 2024, featuring Cora Meese, EVP, Director of Growth and Account Services, Entrée Health
  • The Importance of representation in healthcare marketing, featuring Megan Hall, EVP, Executive Creative Director, Entrée Health
  • Hot topics in market access, featuring Andrew Gottfried, CEO, Entrée Health
  • Pressing issues in the coming election year, featuring Douglas Bock, Partner, Archbow Consulting, and Dina Steinfurth, Managing Director, Valuate Health Consultancy
• Reimbursement Blueprint: A 4-Step Guide to a Successful Pharmaceutical Hub (webinar archive), by Archbow Consulting and Entrée Health
• Is Hub Optimization the Key for Drug Launches? (podcast), featuring Justine Hughes, Vice President, Archbow Consulting
• Are Alternative Distribution Models a Viable Option for Pharma? (Pharmaceutical Commerce), by Rob Besse, Vice President, Archbow Consulting
• Case Study: Helping Field Teams Navigate Complex Health Systems, by Valuate Health Consultancy
• 2024 Predictions from MM+M Agency 100 Honorees, featuring Megan Hall, EVP, Executive Creative Director, Entrée Health

For more market access content like this, connect with us on LinkedIn (Archbow Consulting, Entrée Health, Valuate Health Consultancy), read the blog, listen to the podcast, or subscribe to our Market Access Musings Newsletter.

Archbow Consulting, Entrée Health, and Valuate Health Consultancy are sister companies that work collaboratively to deliver comprehensive market access solutions to the pharma and biotech industry.  

For additional insights on this topic, you may also enjoy the following related blog posts:

Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.

Share in